In breast cancer, triple-negative breast cancer (TNBC) is a complicated and aggressive subtype of breast cancer that lacks estrogen receptors, progesterone receptors, and HER2 amplification, making it difficult to target therapeutically. Here, PGR is linked to breast carcinoma.